Inventiva Pharma
About:
Inventiva is a biopharmaceutical company with several drug candidates at clinical and preclinical stage.
Website: http://www.inventivapharma.com
Twitter/X: inventivapharma
Top Investors: European Investment Bank, Andera Partners, AbbVie, European Commission, Perceptive Advisors
Description:
Inventiva Pharma is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical needs in the areas of fibrosis, lysosomal storage disorders and oncology. They have built a pipeline backed by a discovery engine with an extensive library of proprietary molecules, a wholly-owned research and development facility and a team with significant expertise and deep experience in the development of compounds that target nuclear receptors, transcription factors and epigenetic modulation. Leveraging these assets and expertise, they are advancing two clinical candidates in three indications, as well as a deep pipeline of earlier stage programs.
$283M
$10M to $50M
Daix, Bourgogne, France
2011-01-01
info(AT)inventivapharma.com
Frederic Cren, Pierre Broqua
101-250
2024-10-14
Public
© 2025 bioDAO.ai